# Embrace: Seizure Characterization

> **NCT03206502** · NA · ENROLLING_BY_INVITATION · sponsor: **Empatica, Inc.** · enrollment: 100000 (estimated)

## Conditions studied

- Epilepsy

## Interventions

- **DEVICE:** Embrace + Alert App

## Key facts

- **NCT ID:** NCT03206502
- **Lead sponsor:** Empatica, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2016-05
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 100000 (ESTIMATED)
- **Last updated:** 2020-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03206502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03206502, "Embrace: Seizure Characterization". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03206502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*